Three individuals who have detransitioned are sharing their experiences, alleging that medical professionals and institutions unduly influenced them, particularly during their teenage years, to pursue gender transition treatments, including medical interventions for two of them while still minors. These accounts are detailed in a recent report commissioned by the Department of Health and Human Services (HHS).
HHS Report Details Concerns Over Youth Gender Treatments
The HHS-commissioned report, titled “Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of ‘Gender Medicine,'” highlights the testimonies of Clementine Breen, Soren Aldaco, and Luke Healy. Released on a Thursday, the report not only presents these personal narratives but also raises questions about potential financial incentives that may have driven hospitals and doctors toward offering gender transition therapies. It specifically points to insurance billing practices that warrant further scrutiny.
Clementine Breen’s Journey: From Early Intervention to Regret
Clementine Breen’s experience began at the age of 12. According to the HHS report, Breen was grappling with the physical changes of adolescence and the lingering effects of past sexual abuse. The report states that doctors at Children’s Hospital Los Angeles informed Breen’s parents that the pre-teen was “100% trans” and faced a high risk of suicide if medical interventions were not pursued. Consequently, Breen started puberty blockers at 12, began testosterone therapy at 13, and underwent a double mastectomy at 14.
The report indicates that Breen’s mental health declined, and by age 18, after undergoing therapy, Breen concluded that the distress related to gender identity was intertwined with earlier trauma. This led to discontinuing testosterone and experiencing physical consequences, including pain and irregular menstrual cycles, necessitating estrogen therapy. When Breen later sought breast reconstruction, the report notes a stark contrast in how the individual was treated; doctors reportedly questioned Breen’s mental stability and some ceased communication, a level of scrutiny Breen did not face when seeking a mastectomy at a younger age. The medical record, according to the report, also contained notations of a lifelong history of gender dysphoria. Now a UCLA theater student, Breen expressed in the report concerns about the long-term physical impacts of the treatments and surgery, questioning the capacity of a child to consent to irreversible procedures like the loss of fertility or the ability to breastfeed without a full understanding of the implications.
Soren Aldaco: Online Influence and Insufficient Support
Soren Aldaco’s gender-related distress surfaced during adolescence, with online communities presenting gender transition as the “appropriate response” to these feelings, the report details. After consulting with a doctor, Aldaco was prescribed testosterone, and multiple specialists managed Aldaco’s gender dysphoria. The report suggests that providers did not adequately explore alternative treatments, adhering instead to what it characterizes as a “sex rejection” model. Aldaco underwent a double mastectomy before starting testosterone. The report states that Aldaco experienced severe post-surgical complications, leading to pain that the individual described as unforgettable. Despite these negative outcomes, the report notes a lack of structured reassessment of Aldaco’s treatment plan and insufficient post-treatment support compared to the coordinated efforts that facilitated the initial transition decisions. “Soren’s experience reflects the imbalance of care for cases like hers,” the report reads. “While her pathway into sex rejection medicalization involved coordinated referrals, approvals, and interventions across multiple providers, the pathway out involved no comparable system of support.”
Luke Healy: Parental Prudence and Commercialized Care
Luke Healy’s awareness of transgender identities began around age 10 through an online community. Within three years, Healy started identifying as a girl. While Healy’s parents sought counseling for their child, the report indicates that they were the only ones to seriously explore the potential causes of Healy’s distress. In contrast, “institutional figures… treated his new identity as settled and moved quickly to affirm it.” Healy’s parents notably refused to consent to puberty blockers or hormone therapy while Healy was a minor, a decision Healy now views as crucial.
Upon reaching 18, Healy pursued transition treatments, starting with estrogen and exploring surgical options. However, the report states that these interventions did not alleviate psychological stress. Healy began to question the recommended procedures, with one doctor quoting approximately $200,000 for facial feminization surgery and another reportedly engaging in high-pressure sales tactics for a tracheal shave. Healy perceived this as being “sold procedures, not psychological help.” Ultimately, Healy shifted focus from gender transition to addressing substance abuse issues that developed during the process, recognizing a parallel between the obsessive patterns seen in addiction and gender ideology. The report suggests a model built around “escalation rather than resolution.”
Broader Implications and Concerns
The accounts presented in the HHS report raise significant questions about the protocols and motivations surrounding gender-affirming care for minors. The alleged financial incentives and the nature of the medical advice provided to vulnerable young people are central to the report’s findings. The experiences of Breen, Aldaco, and Healy underscore a call for greater scrutiny and potentially a re-evaluation of how medical institutions approach gender dysphoria in adolescents, emphasizing the need for comprehensive mental health support that explores all potential contributing factors before irreversible medical steps are taken.
The report’s findings suggest a critical need for a more balanced approach, ensuring that young people exploring their gender identity receive thorough psychological evaluation and support, with medical interventions considered only after all other avenues have been explored and with full, informed consent regarding long-term consequences. The experiences detailed highlight a perceived gap in care, where the pathway into medical transition appears more streamlined and supported than the pathway out, should individuals later decide to detransition.
